Omega Healthcare Investors (BSP:O2HI34) Future 3-5Y EPS without NRI Growth Rate: N/A (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
46 GF Score
Price R$81.84
GF Value R$70.35
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Omega Healthcare Investors Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Omega Healthcare Investors's Future 3-5Y EPS without NRI Growth Rate is N/A.


Omega Healthcare Investors  (BSP:O2HI34) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Omega Healthcare Investors Future 3-5Y EPS without NRI Growth Rate Related Terms


BSP:O2HI34 vs DOC, AHR, CTRE: Future 3-5Y EPS without NRI Growth Rate Comparison

For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omega Healthcare Investors Future 3-5Y EPS without NRI Growth Rate vs REITs Industry

For the REITs industry and Real Estate sector, Omega Healthcare Investors's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Omega Healthcare Investors's Future 3-5Y EPS without NRI Growth Rate falls into.


BSP:O2HI34
46GF Score
Omega Healthcare Investors Inc BSP:O2HI34
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$81.84 is trading 16.3% above its estimated GF Value™ of R$70.35. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • Future 3-5Y EPS without NRI Growth Rate: N/A
  • GF Value™: R$70.35 vs. price of R$81.84 (16.3% above fair value)
  • GF Score™: 46/100 with 7 warning signs

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
46GF Score

Get the complete analysis for BSP:O2HI34

Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$81.84
Price
R$70.35
GF Value